BrainsWay appoints medtech industry vet as its new CEO

By Emily Bader
Hackensack | Nov 25, 2019 at 11:40 am

BrainsWay Ltd., an Israeli-based medical device company with operations in Hackensack, announced on Monday its board of directors has appointed Dr. Christopher von Jako as its new CEO and president, effective January 2020.

“Dr. von Jako is a science-driven senior executive with over 25 years of experience managing businesses and leading global medical technology companies,”  Dr. David Zacut, a co-founder of BrainsWay and chairman of the board, who has been serving as Interim CEO since September, said. “Most importantly, he has significant expertise in developing and commercializing minimally-invasive medical technologies aimed at improving patient experiences and outcomes. We are highly confident that Dr. von Jako is well-suited to lead BrainsWay into its next phase of growth.”

Prior to BrainsWay, von Jako served as CEO of Dynatronics Corp. Before that, he was the CEO and president of NinePoint Medical Inc. Additionally, he served as CEO and president of NeuroTherm Inc. Earlier in his career, he held senior roles with other leading medical device companies, such as Integra LifeSciences, Covidien, Medtronic and Radionics.

“I am incredibly honored and grateful to the Board for the opportunity to lead this exceptional organization,” von Jako said. “BrainsWay has done an excellent job of developing and obtaining regulatory clearances for its innovative Deep Transcranial Magnetic Stimulation system in multiple large indications. Market demand for Deep TMS continues to grow, and I look forward to working with the management team and the Board to further accelerate BrainsWay’s commercialization and market adoption efforts in the U.S. and around the globe.”

Read more from ROI-NJ: